Partnering
Together we can shape the future of healthcare
:quality(90)/)
Roche announces global partnership with Nurix Therapeutics
To advance bexobrutideg, a potential best-in-class Bruton's Tyrosine Kinase (BTK) degrader for people living with B-cell malignancies.
We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and delivering them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.
Partnering with Pharma
>240 partnerships
60% of our R&D pipeline and total Pharma sales involve a partnership
140 people worldwide focused on bringing in and managing lasting partnerships
Partnering with Diagnostics
75 new agreements in 2025
24 acquisitions since 2014
+20 years of partnering with companies and research institutes globally to advance health
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)